hydralazine has been researched along with Auricular Fibrillation in 10 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is a powerful risk factor of atrial fibrillation (AF)." | 1.42 | Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats. ( Chishaki, A; Hirooka, Y; Inoue, S; Kishi, T; Mukai, Y; Nagayama, T; Sunagawa, K; Takase, S; Takemoto, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagayama, T | 1 |
| Hirooka, Y | 1 |
| Kishi, T | 1 |
| Mukai, Y | 1 |
| Inoue, S | 1 |
| Takase, S | 1 |
| Takemoto, M | 1 |
| Chishaki, A | 1 |
| Sunagawa, K | 1 |
| Kopecky, SL | 1 |
| Litin, SC | 1 |
| Mitchell, JE | 1 |
| Tam, SW | 1 |
| Trivedi, K | 1 |
| Taylor, AL | 1 |
| O'Neal, W | 1 |
| Cohn, JN | 2 |
| Worcel, M | 1 |
| Alloway, JA | 1 |
| Salata, MP | 1 |
| Carson, PE | 1 |
| Johnson, GR | 1 |
| Dunkman, WB | 1 |
| Fletcher, RD | 1 |
| Farrell, L | 1 |
| Stevenson, WG | 1 |
| Stevenson, LW | 1 |
| Middlekauff, HR | 1 |
| Fonarow, GC | 1 |
| Hamilton, MA | 1 |
| Woo, MA | 1 |
| Saxon, LA | 1 |
| Natterson, PD | 1 |
| Steimle, A | 1 |
| Walden, JA | 1 |
| Tillisch, JH | 1 |
| Li, D | 1 |
| Shinagawa, K | 1 |
| Pang, L | 1 |
| Leung, TK | 1 |
| Cardin, S | 1 |
| Wang, Z | 1 |
| Nattel, S | 1 |
| Taguchi, J | 1 |
| Freis, ED | 1 |
| Belic, N | 1 |
| Talano, JV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00047775] | Phase 4 | 1,100 participants | Interventional | 2001-05-31 | Completed | ||
| Congestive Heart Failure Atrial Arrhythmia Monitoring and Pacing (CHAMP)[NCT00156728] | Phase 4 | 172 participants | Interventional | 2003-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydralazine and Auricular Fibrillation
| Article | Year |
|---|---|
Quinidine-induced rheumatic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Atrial Fibrillation; Child; Diagnosis, Diff | 1995 |
4 trials available for hydralazine and Auricular Fibrillation
| Article | Year |
|---|---|
Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT).
Topics: Atrial Fibrillation; Black or African American; Drug Combinations; Female; Follow-Up Studies; Heart | 2011 |
The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
Topics: Atrial Fibrillation; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isoso | 1993 |
Partial versus complete control of blood pressure in the prevention of hypertensive complications.
Topics: Atrial Fibrillation; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Follow-Up St | 1975 |
Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects.
Topics: Adult; Age Factors; Aged; Aneurysm; Atrial Fibrillation; Blood Glucose; Blood Pressure; Cerebrovascu | 1972 |
5 other studies available for hydralazine and Auricular Fibrillation
| Article | Year |
|---|---|
Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; A | 2015 |
Clinical pearls in cardiology.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cardiomyopathy, Dilated; Diuretics; Female; Heart Failure | 2010 |
Improving survival for patients with atrial fibrillation and advanced heart failure.
Topics: Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fi | 1996 |
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Dogs; Electr | 2001 |
Current concepts in sick sinus syndrome. II. ECG manifestation and diagnostic and therapeutic approaches.
Topics: Atrial Fibrillation; Atropine; Bradycardia; Cardiac Pacing, Artificial; Electric Stimulation; Electr | 1985 |